130 related articles for article (PubMed ID: 17895771)
1. Safety of statin therapy in HIV/hepatitis C virus-coinfected patients.
Milazzo L; Menzaghi B; Corvasce S; Bonfanti P; Rusconi S; Ridolfo AL; Antinori S
J Acquir Immune Defic Syndr; 2007 Oct; 46(2):258-60. PubMed ID: 17895771
[No Abstract] [Full Text] [Related]
2. Antiretroviral drugs and liver injury.
Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
[No Abstract] [Full Text] [Related]
3. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
Mehta SH; Thomas DL; Torbenson M; Brinkley S; Mirel L; Chaisson RE; Moore RD; Sulkowski MS
Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
[TBL] [Abstract][Full Text] [Related]
4. Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologic responders?
Gavazzi G; Bouchard O; Leclercq P; Morel-Baccard C; Bosseray A; Dutertre N; Micoud M; Morand P
AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1021-3. PubMed ID: 10933615
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
Torti C; Lapadula G; Casari S; Puoti M; Nelson M; Quiros-Roldan E; Bella D; Pastore G; Ladisa N; Minoli L; Sotgiu G; Mazzotta F; Lo Caputo S; Di Perri G; Filice G; Tinelli C; Carosi G;
BMC Infect Dis; 2005 Jul; 5():58. PubMed ID: 16018804
[TBL] [Abstract][Full Text] [Related]
6. Incidence of statin hepatotoxicity in patients with hepatitis C.
Khorashadi S; Hasson NK; Cheung RC
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):902-7; quiz 806. PubMed ID: 16697272
[TBL] [Abstract][Full Text] [Related]
7. De-"Liver"-ing HIV/hepatitis C virus-coinfected patients from antiretroviral hepatotoxicity.
Cooper CL
J Infect Dis; 2007 Sep; 196(5):656-8. PubMed ID: 17674305
[No Abstract] [Full Text] [Related]
8. HIV and hepatitis C virus co-infection.
Sulkowski M
Hopkins HIV Rep; 1998 Nov; 10(6):8, 12. PubMed ID: 11366132
[TBL] [Abstract][Full Text] [Related]
9. Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.
Kang F; Chen W; Zhang X; Nie W; Fu J; Xu X; Zhao P; Zhang X; Li W; Wang FS; Zhang Z; Zhao M
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):135-42. PubMed ID: 23075912
[TBL] [Abstract][Full Text] [Related]
10. Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
Casado JL; Mena A; Bañón S; Castro A; Quereda C; Moreno A; Pedreira J; Moreno S
HIV Med; 2016 Jan; 17(1):62-7. PubMed ID: 26122981
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection.
French AL; Benning L; Anastos K; Augenbraun M; Nowicki M; Sathasivam K; Terrault NA
Clin Infect Dis; 2004 Aug; 39(3):402-10. PubMed ID: 15307009
[TBL] [Abstract][Full Text] [Related]
12. [HIV infection: from Pneumocystis to statins].
Palacios Muñoz R; Santos González J
Med Clin (Barc); 2006 Jul; 127(7):253-4. PubMed ID: 16942728
[No Abstract] [Full Text] [Related]
13. The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy.
Melvin DC; Lee JK; Belsey E; Arnold J; Murphy RL
AIDS; 2000 Mar; 14(4):463-5. PubMed ID: 10770552
[No Abstract] [Full Text] [Related]
14. Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.
Di Biagio A; Nicolini LA; Lorenzini P; Puoti M; Antinori A; Cozzi-Lepri A; Gori A; Vecchiet J; Mussini C; Andreoni M; Viscoli C; d'Arminio Monforte A; For The Icona Foundation Study Group
HIV Clin Trials; 2014; 15(4):151-60. PubMed ID: 25143024
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation in a patient coinfected with human immunodeficiency virus and hepatitis C virus.
González Alonso R; Bárcena R; Blesa C; Garcia M; Moreno A; Fortun J; Martin P; Quereda C; de Vicente E
Transplant Proc; 2003 Aug; 35(5):1846-7. PubMed ID: 12962819
[No Abstract] [Full Text] [Related]
16. Effectiveness and hepatotoxicity of statins in men seropositive for hepatitis C virus.
Segarra-Newnham M; Parra D; Martin-Cooper EM
Pharmacotherapy; 2007 Jun; 27(6):845-51. PubMed ID: 17542767
[TBL] [Abstract][Full Text] [Related]
17. Acute liver enzyme elevations in HIV-1-infected patients.
Livry C; Binquet C; Sgro C; Froidure M; Duong M; Buisson M; Grappin M; Quantin C; Portier H; Chavanet P; Piroth L
HIV Clin Trials; 2003; 4(6):400-10. PubMed ID: 14628283
[TBL] [Abstract][Full Text] [Related]
18. HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels.
Gonzalez SA; Liu RC; Edlin BR; Jacobson IM; Talal AH
J Acquir Immune Defic Syndr; 2006 Apr; 41(5):582-9. PubMed ID: 16652026
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
den Brinker M; Wit FW; Wertheim-van Dillen PM; Jurriaans S; Weel J; van Leeuwen R; Pakker NG; Reiss P; Danner SA; Weverling GJ; Lange JM
AIDS; 2000 Dec; 14(18):2895-902. PubMed ID: 11153671
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.
Collazos J; Cartón JA; Asensi V
HIV Med; 2011 May; 12(5):308-15. PubMed ID: 20946441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
